ArticleMicromachines2025
Miniaturized Dual and Quad Port MIMO Antenna Variants Featuring Elevated Diversity Performance for UWB and 5G-Midband Applications.
Article in Micromachines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The growing demand for high-speed and high-capacity wireless communication has intensified the need for compact, wideband, and efficient MIMO antenna systems, particularly for 5G mid-band and UWB applications. This article presents a miniaturized dual and quad port MIMO antenna design optimized for 5G mid-band (n77/n78/n79/n96/n102) and Ultra-Wideband (UWB) applications without employing any decoupling structures between the radiating elements. The 2-port configuration features two closely spaced symmetric monopole elements (spacing < λ
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.